Prescribing in maternity care in Russia: The legacy of Soviet medicine

Health Policy

Volumn 85, Issue 2, 2008, Pages 242-251

  Danichevski, Kirill ^a,b   McKee, Martin ^b   Balabanova, Dina ^b  

^a Open Health Institute   (Russian Federation)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Obstetrics; Prescribing; Russia

Indexed keywords

ARTICLE; AWARENESS; DRUG INDUSTRY; EVIDENCE BASED MEDICINE; INFORMATION SERVICE; MATERNAL CARE; MEDICAL PRACTICE; OBSTETRICS; RUSSIAN FEDERATION; STRUCTURED INTERVIEW;

EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; INFANT, NEWBORN; INTERVIEWS AS TOPIC; MATERNAL-CHILD NURSING; MOSCOW; OBSTETRICS; PHYSICIANS; PREGNANCY; PRESCRIPTIONS, DRUG; QUESTIONNAIRES;

EID: 37349021713     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healthpol.2007.08.001     Document Type: Article

References (45)

1. Conroy M.S. The Soviet pharmaceutical business during its first two decades (1917-1937) (2006), Peter Lang, Bern
2. Andreev E.M., Nolte E., Shkolnikov V.M., Varavikova E., and McKee M. The evolving pattern of avoidable mortality in Russia. International Journal of Epidemiology 32 3 (2003) 437-446
3. Duke T., Keshishiyan E., Kuttumuratova A., Ostergren M., Ryumina I., Stasii E., et al. Quality of hospital care for children in Kazakhstan, Republic of Moldova, and Russia: systematic observational assessment. The Lancet 367 9514 (2006) 919-925
4. Balabanova Y., Fedorin I., Kuznetsov S., Graham C., Ruddy M., Atun R., et al. Antimicrobial prescribing patterns for respiratory diseases including tuberculosis in Russia: a possible role in drug resistance?. Journal of Antimicrobial Chemotherapy 54 3 (2004) 673-679
5. Danishevski K., Balabanova D., McKee M., Nolte E., Schwalbe N., and Vasilieva N. Inequalities in birth outcomes in Russia: evidence from Tula oblast. Paediatric and Perinatal Epidemiology 19 5 (2005) 352-359
6. Danishevski K., Balabanova D., McKee M., and Parkhurst J. Delivering babies in a time of transition in Tula, Russia. Health Policy and Planning 21 3 (2006) 195-205
7. Lumley J, Watson L, Watson M, Bower C. Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database Systematic Review 2001;(3):CD001056.
8. Ylikorkala O., Kauppila A., and Ollanketo M.L. Intramuscular ACTH or placebo in the treatment of hyperemesis gravidarum. Acta Obstetricia et Gynecologica Scandinavica 58 5 (1979) 453-455
9. Jewell D, Young G. Interventions for nausea and vomiting in early pregnancy. Cochrane Database Systematic Review 2003;(4):CD000145.
10. Goldman A.S., and Bongiovanni A.M. Induced genital anomalies. Annals of the New York Academy of Sciences 142 3 (1967) 755-767
11. Ensom M.H., and Stephenson M.D. Low-molecular-weight heparins in pregnancy. Pharmacotherapy 19 9 (1999) 1013-1025
12. Duley L, Henderson-Smart DJ, Knight M, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Systematic Review 2004;(1):CD004659.
13. Mattar F., and Sibai B.M. Prevention of preeclampsia. Seminars in Perinatology 23 1 (1999) 58-64
14. Duley L, Henderson-Smart D. Magnesium sulphate versus phenytoin for eclampsia. Cochrane Database Systematic Review 2003;(4):CD000128.
15. Royal College of Obstetricians and Gynaecologists. Induction of labour. London: RCOG; 2001.
16. Singh K.C., Jain P., Goel N., and Saxena A. Drotaverine hydrochloride for augmentation of labor. International Journal of Gynaecology and Obstetrics 84 1 (2004) 17-22
17. Sharma J.B., Pundir P., Kumar A., and Murthy N.S. Drotaverine hydrochloride vs. valethamate bromide in acceleration of labor. International Journal of Gynaecology and Obstetrics 74 3 (2001) 255-260
18. Romics I., Molnar D.L., Timberg G., Mrklic B., Jelakovic B., Koszegi G., et al. The effect of drotaverine hydrochloride in acute colicky pain caused by renal and ureteric stones. BJU International 92 1 (2003) 92-96
19. Anteka online. http://www.aptekaonline.ru/card_mnn_m_id-61.html; 2007.
20. Petrie R.H., and Danilo Jr. P. Maternal and fetal effects of uterine stimulants and relaxants. Diagnostic Gynecology and Obstetrics 3 2 (1981) 111-117
21. Lapinski Z., Launanski T., and Zasztowt O. Administration of ATP in the preparation of the uterus for labor. Zentralblatt fur Gynakologie 95 1 (1973) 652-656
22. Horska S., Stembera Z.K., and Vondracek J. The effect of ATP on the fetus in danger during labour. The Journal Obstetrics and Gynaecology of the British Commonwealth 77 11 (1970) 998-1002
23. Cazzola D. Our experience with induced and directed labor. Minerva Ginecology 26 12 (1974) 756-761
24. Weeks A., and Alfirevic Z. Oral misoprostol administration for labor induction. Clinical Obstetrics and Gynecology 49 3 (2006) 658-671
25. Derman R.J., Kodkany B.S., Goudar S.S., Geller S.E., Naik V.A., Bellad M.B., et al. Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial. The Lancet 368 9543 (2006) 1248-1253
26. Ammari A.N., and Schulze K.F. Uses and abuses of sodium bicarbonate in the neonatal intensive care unit. Current Opinion in Pediatrics 14 2 (2002) 151-156
27. Dennery P.A. Pharmacological interventions for the treatment of neonatal jaundice. Seminars in Neonatology 7 2 (2002) 111-119
28. Zar H.J. Neonatal chlamydial infections: prevention and treatment. Paediatrics Drugs 7 2 (2005) 103-110
29. Manelis E.S. Transplacental passage of sodium oxybutyrate in parturients. Anesteziology and Reanimatology 4 (1980) 12-14
30. Maitre M., Humbert J.P., Kemmel V., Aunis D., and Andriamampandry C. A mechanism for gamma-hydroxybutyrate (GHB) as a drug and a substance of abuse. Medical Science (Paris) 21 3 (2005) 284-289
31. Actovegin. http://www.actovegin.ru/; 2007.
32. Nycomed. http://www.nycomed.com/en/Menu/Products/Actovegin.htm; 2007.
33. Panovir. http://www.panavir.com/; 2007.
34. Kulier R, Gulmezoglu AM, Hofmeyr GJ, Cheng LN, Campana A. Medical methods for first trimester abortion. Cochrane Database Systematic Review 2004;(2):CD002855.
35. Betts P.R., Logatchov M., Volkov I., Murphy H., Dombrowskaya N., Borzikh S., et al. An assessment of paediatric diabetes care in three centres in Russia and in Southampton, UK. The Paediatric Teams in Moscow, Tula, Tambov, Southampton. Diabetic Medicine 16 9 (1999) 772-778
36. Krementosov N.L. Stalinist science (1997), Princeton University Press, Princeton, NJ/Chichester
37. Joravsky D. The Lysenko affair (1986), University of Chicago Press, Chicago
38. Cochrane A.L. Effectiveness and efficiency: random reflections on health services (1999), Royal Society of Medicine Press, London
39. McKee M. Cochrane on communism: the influence of ideology on the search for evidence. International Journal of Epidemiology 36 (2007) 269-273
40. Rieder M.J. Paediatric clinical pharmacology in the former Soviet Union: Ukraine. Biology and Neonate 68 4 (1995) 276-281
41. Vlassov V., Mansfield P., Lexchin J., and Vlassova A. Do drug advertisements in Russian medical journals provide essential information for safe prescribing?. Western Journal of Medicine 174 6 (2001) 391-394
42. Tregakes E., and Lessof S. Health systems in transition: Russian Federation Copenhagen. European Observatory on Health Systems and Policies (2003)
43. Rese A., Balabanova D., Danishevski K., McKee M., and Sheaff R. Implementing general practice in Russia: getting beyond the first steps. British Medical Journal 331 7510 (2005) 204-207
44. Internet World Stats. http://www.internetworldstats.com/euro/ru.htm; 2007.
45. Vacroux A. Regulation and corruption in transition: the case of the Russian pharmaceutical markets. In: Kornai J., and Rose-Ackerman S. (Eds). Building a Trustworthy state in post-socialist transition (2004), Palgrave Macmillan, New York 133-150